Investment thesis
Founded in 1997 and backed by Natixis Investment Managers, Seventure Partners is one of Europe's longest-running venture firms, managing around €1 billion from Paris with offices in Munich, London, Geneva and Basel. It invests from early to late stage, typically €500,000 to €10 million per round and up to €20 million per company, across life sciences and digital technologies. Its Health for Life Capital funds made it the reference investor in microbiome, nutrition and gut health, alongside medtech, digital health, industrial biotech and animal health, while the digital practice covers fintech, retailtech, hardware and telecom. Dedicated vehicles address sport and performance and the blue economy, from sustainable aquaculture to biopolymers and biopackaging.
Past investments
| Company | Round | Date | Round size |
|---|---|---|---|
| Microbiotica Cambridge, United Kingdom | Series C | Oct 2026 | €42.7M |
| ANote Music Luxembourg City, Luxembourg | - | Sep 2026 | €2M |
| Hackuity Lyon, France | - | Sep 2026 | €16.4M |
| Standing Ovation Paris, France | Series B | Apr 2026 | €30M |
| La Vie Paris, France | Series A | Jan 2022 | €25M |
| The Akkermansia Company Louvain-la-Neuve, Belgium | Series A | Apr 2018 | €13M |
| Eligo Bioscience Paris, France | Series A | Jul 2015 | €2M |
| MaaT Pharma Lyon, France | Seed | Jan 2015 | €1M |
| Enterome Paris, France | Series B | May 2014 | €10M |